IP Library Granted Patent US 9,511,191
Granted Patent B2
US 9,511,191 · App. 14/353,523 · Granted Dec 6, 2016

Medicament guiding assembly for a drug delivery device

Inventors: Marc Holtwick (Frankfurt am Main, DE); Martin Haupt (Vienna, AT)
Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
A61M5/31A61M5/20B29C45/1671A61M5/141A61M5/19A61M5/24A61M2005/1787A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,511,191
App. No.
14/353,523
Granted
Dec 6, 2016
Kind
B2
Abstract

A fluid guiding assembly for a drug delivery device is presented having a first member, a cover part adjacently disposed to the first member and being in non-bonded surface contact with a surface portion of the first member thereby forming an interface area, at least one channel structure extending along the interface area of first member and cover part and being formed by at least one recess in either the first member and/or in the cover part, and a second member being in contact with the cover part and being bonded to the first member by way of injection molding to fix the cover part relative to the first member.

Claims (26)

1. A drug delivery device adapted to dispense a predefined amount of a medicament via an outlet, comprising:

a housing to receive at least one cartridge at least partially filled with a medicament,

a dispensing end to dispense a predefined amount of the medicament, and

a fluid guiding assembly disposed between the cartridge and the dispensing end, wherein the fluid guiding assembly comprises:

a first member,

a cover part adjacently disposed to the first member and being in non-bonded surface contact with a surface portion of the first member thereby forming an interface area, wherein the interface area is defined by surface portions of the first member and the cover part that are in direct contact with each other,

at least one channel structure located in the interface area and extending along the interface area of first member and cover part and being formed by at least one recess in either the first member and/or in the cover part,

wherein the at least one channel structure of the fluid guiding assembly is arranged in a fluid path between the cartridge and the dispensing end, and

a second injection molded member being in contact with the cover part and being bonded to the first member by way of injection molding to fix the cover part relative to the first member and wherein there is provided a substance-to-substance bonding between the first and the second member.

2. The drug delivery device according to claim 1 , wherein the first member comprises an injection molded plastic component.

3. The drug delivery device according to claim 1 , wherein the second member comprises an injection molded plastic component.

4. The drug delivery device according to claim 1 , wherein the cover part and/or the first member comprise an inert plastic material.

5. The drug delivery device according to claim 1 , wherein first and second members are mutually interconnected in regions outside the cover part.

6. The drug delivery device according to claim 1 , wherein the second member and/or the first member at least partially enclose the cover part.

7. The drug delivery device according claim 1 , wherein the interface between cover part and first member is substantially liquid-tight.

8. The drug delivery device according to claim 1 , wherein the guiding assembly is designed as a needle hub or as a cartridge hub of the drug delivery device.

9. The drug delivery device according to claim 1 , wherein the first member comprises an undercutting or indentation in a surface portion that is in bonding contact with the second member.

10. The drug delivery device according to claim 1 , wherein the second member laterally embraces or laterally encloses a lateral side edges of the first member and wherein the second member at least partially extends across a lower surface of the first member facing away from the cover part.

11. The drug delivery device according to claim 1 , wherein the material the second member is made of exhibits a higher shrinkage rate compared to the material the first member or the cover part is made of.

12. A method of manufacturing a drug delivery device according to claim 1 , comprising the steps of:

providing a first member,

arranging a cover part adjacent to the first member to form an interface area in which first member and cover part get in direct contact with each other, wherein the cover part and/or the first member comprise at least one recess extending along the interface area to form a channel structure,

engaging the first member with a second member at least being in contact with the cover part to fix the same relative to the first member, and

bonding the second member to the first member by way of injection molding after first member and cover part have been mutually assembled.

13. The method according to claim 12 , wherein the first member and/or the cover part are injection molded and comprise at least one recess extending across an interface forming surface portion.

14. The method according to claim 12 , wherein the cover part is sealingly pressed against the first member during injection molding of the second member.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: HOLTWICK, MARC; HAUPT, MARTIN
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 033539/0082 →
Priority Claims (1)
EP 11189282 · Nov 16, 2011 · regional
Continuity (1)
Related Publication 20140316341A1 · Oct 23, 2014